- Myasthenia Gravis Treatment: 5 Things to Know - Medscape
Myasthenia gravis, a rare autoimmune disease, can have devastating consequences Stay current on the latest and emerging MG treatments with these five things to know
- Key Updates in Myasthenia Gravis From AANEM 2025 - Medscape
Myasthenia gravis updates from AANEM 2025 include efficacy data for efgartigimod, telitacicept, and gefurulimab, plus interim results for a CAR T-cell therapy and DNTH10, an active C1S inhibitor
- Early Detection of MG May Lessen Symptom Severity - Medscape
Early detection of myasthenia gravis, along with timely treatment, could mitigate symptom severity and optimize outcomes, reports Dr Nicholas Silvestri
- AAN 2025: Key Highlights of Advances in Myasthenia Gravis - Medscape
Dr Nicholas Silvestri reports that the 2025 AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics and emerging therapies
- Self-Injected Med Shows Rapid, Sustained Benefit in gMG - Medscape
Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key
- Myasthenia Gravis: Which Test Is Best? When and Why?
Drs Nicholas Silvestri and Carolina Barnett-Tapia discuss what you need to know about immunopathogenesis and diagnosis for this relatively rare condition
- Conference MDAngle: AANEM 2025 Myasthenia Gravis - Medscape
Insights from AANEM 2025, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care
- Myasthenia Gravis: What Role Does Heredity Play? - Medscape
SAVANNAH, GEORGIA — One patient with autoimmune myasthenia gravis (MG) has a niece with the same diagnosis, and at least one of his other close relatives may have it too Another patient with MG
|